Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. COF
6. SMCI
7. RTX
8. TSLA
9. GOOGL
10. S

Go back to Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results

Gilead Sciences (GILD) Misses Q4 EPS by 83c; Offers 2022 Guidance

February 1, 2022 4:04 PM EST

Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $0.69, $0.83 worse than the analyst estimate of $1.52. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.51 billion.

GUIDANCE:

Gilead Sciences sees FY2022 EPS of $6.20-$6.70, versus the consensus of... More